News and updates

from the frontier in AI biomarkers

AI biomakers to transform oncology

AI biomarkers will transform oncology with new maps for tumor biology and breakthrough predictors for treatment response. We have the opportunity to improve outcomes for every cancer patient with AI-driven insights from digital pathology.

Alan Aberdeen headshot

Alan Aberdeen

Co-founder